Clínic Barcelona
Clínic Barcelona
June 28 2013
News from June 2013
- Jan (26)
- Feb (38)
- Mar (27)
- Apr (28)
- May (25)
- Jun (27)
- Jul (29)
- Aug (7)
- Sep (51)
- Oct (171)
- Nov (208)
- Dec (6)
- Jan (4)
- Feb (25)
- Mar (18)
- Apr (17)
- May (21)
- Jun (23)
- Jul (23)
- Aug (13)
- Sep (11)
- Oct (62)
- Nov (73)
- Dec (24)
Clínic Barcelona
Clínic Barcelona
June 27 2013
A project led by Oliva Dr. Rafael Oliva awarded a Merck Serono Research Grant for Clinical Research
Since 1991, the Fundación Salud 2000 calls annually the Merck Serono Research Grants to fund projects aimed at unpublished research conducted by Span1
Clínic Barcelona
Clínic Barcelona
June 25 2013
Cholesterol accelerates the manifestations of Alzheimer's disease
A new transgenic mouse model, characterized by the overexpression of SREBP-2 and mutations in APP/PS1, allows a better understanding of the relations1
Clínic Barcelona
Clínic Barcelona
June 21 2013
Results of the 26 projects about heart diseases funded by the 2007 TV3 Telethon presented in an academic event
The results of the 26 research projects on heart diseases which were funded by the TV3 Telethon 2007 were presented at the 14th Symposium of the TV31
Clínic Barcelona
Clínic Barcelona
June 21 2013
The Health Connect-EU Group presents the Catalan Strategic Innovation Agenda in Brussels
Members of the Health Connect-EU Group traveled to Brussels on June 18 to present to the European Commission (both Health and Research and Innovation1
Clínic Barcelona
Clínic Barcelona
June 19 2013
Dr. Eduard Batlle explains the complexities of Colorectal Cancer in an IDIBAPS Seminar
Colorectal Cancer (CRC) is one of the leading causes of death by cancer worldwide. Dr. Eduard Batlle leads the Oncology Program and the Colorectal Ca1
Clínic Barcelona
Clínic Barcelona
June 19 2013
FGF21 hormone, key to control obesity, also protects against heart diseases in mice
Clínic Barcelona
Clínic Barcelona
June 17 2013
A population of cells which decreases after pregnancy is related to breast cancer risk
Epidemiological and experimental data suggest that full-term pregnancy (lasting 37 - 40 weeks) at an early age reduces the risk of developing breast1
Clínic Barcelona
Clínic Barcelona
June 14 2013
Genzyme Foundation awards Dr. Pablo Villoslada’s team with a research grant in Multiple Sclerosis
Clínic Barcelona
Clínic Barcelona
June 14 2013